This new, thoroughly revised second edition of the Clinical Manual of Child and Adolescent Psychopharmacology is designed to help clinicians provide state-of-the-art care to their patients and keep up to date with the most recent research. It reflects the reality that child and adolescent psychiatry in general, and psychopharmacology in particular, are rapidly progressing fields that are advancing in multiple directions at once. Because pharmacokinetic processes in children and adolescents can vary significantly from those in adults, it is critical that clinicians have access to the latest information on indications, medications, dosages, interactions, side effects, and off-label use for the pediatric patient population. The book offers clinicians comprehensive information and a multitude of helpful features. Specifically, it: Thoroughly describes and explores those elements that are specific to pediatric psychopharmacology and make it a distinct discipline at the crossroads of child and adolescent psychiatry, pediatrics, and pharmacology. Boasts a Contributors list of leading clinician/scientists, whose insight into the latest research findings and analysis of their clinical implications enable readers to incorporate those findings into their clinical practice. Takes an evidence-based approach to controversial issues in pediatric psychopharmacology, such as attention-deficit/hyperactivity disorder (ADHD) diagnosis and its treatment with psychostimulants, as well as pediatric mood disorders, including bipolar disorder. Examines advances that have been made in understanding the long-term treatment effects of medications in pediatric populations, including the results of head-to-head medication comparison studies that have been completed since the first edition was published. Analyzes recent studies of combination therapies, so that clinicians will better understand how to treat the complex patients that they see every day. Clinicians who bought the first edition will want this revision, as will those just venturing into the pharmacological treatment of children and adolescents. Utterly current, comprehensive, and compelling, the Clinical Manual of Child and Adolescent Psychopharmacology, Second Edition, reflects the major steps that have been made toward improving the evidence-based practice of treating young people with psychiatric illness.In adults, the most common augmentation or combination strategies include adding lithium carbonate at therapeutic levels for a period of 4 weeks, or L- triiodothyronine (T3) (25a50 I¼g/day), or stimulants, or combining an SSRI with a TCAanbsp;...
|Title||:||Clinical Manual of Child and Adolescent Psychopharmacology|
|Author||:||Molly McVoy, Robert L. Findling|
|Publisher||:||American Psychiatric Pub - 2012-10-17|